FXA | FXC | FXA / FXC | |
Gain YTD | 5.327 | 4.836 | 110% |
Net Assets | 68.6M | 61.2M | 112% |
Total Expense Ratio | N/A | N/A | - |
Turnover | N/A | N/A | - |
Yield | 1.26 | 2.24 | 57% |
Fund Existence | 19 years | 19 years | - |
FXA | FXC | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 2 days ago64% | 2 days ago53% |
Momentum ODDS (%) | 2 days ago71% | 2 days ago48% |
MACD ODDS (%) | 2 days ago77% | 2 days ago56% |
TrendWeek ODDS (%) | 2 days ago70% | 2 days ago53% |
TrendMonth ODDS (%) | 2 days ago65% | 2 days ago57% |
Advances ODDS (%) | 2 days ago70% | 2 days ago52% |
Declines ODDS (%) | 7 days ago69% | 7 days ago59% |
BollingerBands ODDS (%) | 2 days ago62% | 2 days ago65% |
Aroon ODDS (%) | 2 days ago70% | 2 days ago66% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QISCX | 26.99 | 0.28 | +1.05% |
Federated Hermes MDT Small Cap Core IS | |||
RSEIX | 14.26 | 0.09 | +0.64% |
Royce Small-Cap Special Equity Instl | |||
PRPFX | 68.81 | N/A | N/A |
Permanent Portfolio Permanent I | |||
ZVNIX | 43.03 | N/A | N/A |
Zevenbergen Growth Institutional | |||
EEMGX | 9.20 | N/A | N/A |
MFS Emerging Markets Equity Research R4 |